Jian Xie's Insider Trades & SAST Disclosures
Jian Xie's most recent trade in Fulgent Genetics Inc was a trade of 4,353 Common Stock done at an average price of $18.9 . Disclosure was reported to the exchange on April 26, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jian Xie.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.88 per share. | 26 Apr 2025 | 4,353 | 374,504 (2%) | 0% | 18.9 | 82,185 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.45 per share. | 01 Mar 2025 | 1,481 | 378,857 (2%) | 0% | 15.4 | 22,881 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 45,304 | 384,889 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 14,297 | 352,390 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 8,031 | 339,585 (1%) | 0% | 16.3 | 130,825 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 8,031 | 339,585 (1%) | 0% | 16.3 | 130,825 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 5,480 | 338,093 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.24 per share. | 25 Feb 2025 | 4,551 | 380,338 (2%) | 0% | 16.2 | 73,908 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.24 per share. | 25 Feb 2025 | 4,551 | 380,338 (2%) | 0% | 16.2 | 73,908 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2025 | 3,384 | 332,613 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 2,951 | 347,616 (1%) | 0% | 16.3 | 48,072 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 2,951 | 347,616 (1%) | 0% | 16.3 | 48,072 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.29 per share. | 25 Feb 2025 | 1,823 | 350,567 (1%) | 0% | 16.3 | 29,697 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.46 per share. | 23 Feb 2025 | 719 | 329,229 (1%) | 0% | 16.5 | 11,835 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.21 per share. | 26 Jan 2025 | 4,733 | 329,948 (1%) | 0% | 17.2 | 81,455 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 19.50 per share. | 03 Dec 2024 | 1,455 | 334,681 (1%) | 0% | 19.5 | 28,372 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | Sale of securities on an exchange or to another person at price $ 18.26 per share. | 25 Nov 2024 | 689 | 336,136 (1%) | 0% | 18.3 | 12,581 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.42 per share. | 26 Oct 2024 | 4,345 | 336,825 (1%) | 0% | 19.4 | 84,380 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 21.96 per share. | 03 Sep 2024 | 1,594 | 341,170 (1%) | 0% | 22.0 | 35,006 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 22.83 per share. | 27 Aug 2024 | 715 | 342,764 (1%) | 0% | 22.8 | 16,326 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.06 per share. | 03 Aug 2024 | 6,719 | 343,479 (1%) | 0% | 25.1 | 168,378 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.66 per share. | 26 Jul 2024 | 4,345 | 350,198 (1%) | 0% | 23.7 | 102,803 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.65 per share. | 01 Jun 2024 | 1,075 | 354,947 (1%) | 0% | 20.7 | 22,199 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.65 per share. | 01 Jun 2024 | 404 | 354,543 (1%) | 0% | 20.7 | 8,343 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.14 per share. | 23 May 2024 | 653 | 356,022 (1%) | 0% | 21.1 | 13,804 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.50 per share. | 03 May 2024 | 6,719 | 356,675 (1%) | 0% | 21.5 | 144,459 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.10 per share. | 26 Apr 2024 | 4,344 | 363,394 (1%) | 0% | 20.1 | 87,314 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.24 per share. | 01 Mar 2024 | 1,075 | 368,142 (1%) | 0% | 23.2 | 24,983 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.24 per share. | 01 Mar 2024 | 404 | 367,738 (1%) | 0% | 23.2 | 9,389 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 25,350 | 369,217 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 6,359 | 349,396 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 3,927 | 343,037 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.26 per share. | 26 Feb 2024 | 3,418 | 343,867 (1%) | 0% | 24.3 | 82,921 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.26 per share. | 26 Feb 2024 | 2,111 | 347,285 (1%) | 0% | 24.3 | 51,213 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.06 per share. | 23 Feb 2024 | 2,612 | 339,110 (1%) | 0% | 24.1 | 62,845 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.65 per share. | 03 Feb 2024 | 6,719 | 351,722 (1%) | 0% | 24.6 | 165,623 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.60 per share. | 26 Jan 2024 | 4,683 | 358,441 (1%) | 0% | 25.6 | 119,885 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | 31 Dec 2023 | 5,700 | 353,124 (1%) | 0% | 101.7 | 579,480 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | 31 Dec 2023 | 4,300 | 358,824 (1%) | 0% | 108.2 | 465,327 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 26.69 per share. | 11 Dec 2023 | 12,000 | 363,124 (1%) | 0% | 26.7 | 320,274 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 26.32 per share. | 11 Dec 2023 | 10,000 | 375,124 (2%) | 0% | 26.3 | 263,179 | Common Stock |
| Fulgent Genetics Inc | Xie Jian | President and COO | Sale of securities on an exchange or to another person at price $ 27.57 per share. | 04 Dec 2023 | 1,779 | 385,124 (2%) | 0% | 27.6 | 49,053 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 33.88 per share. | 17 Aug 2023 | 1,307 | 417,514 (2%) | 0% | 33.9 | 44,283 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.08 per share. | 03 Aug 2023 | 6,198 | 418,821 (2%) | 0% | 40.1 | 248,416 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.83 per share. | 01 Aug 2023 | 775 | 425,019 (2%) | 0% | 38.8 | 30,093 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 40.30 per share. | 02 Jun 2023 | 1,433 | 425,794 (2%) | 0% | 40.3 | 57,744 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 35.46 per share. | 17 May 2023 | 1,320 | 427,227 (2%) | 0% | 35.5 | 46,810 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.33 per share. | 03 May 2023 | 6,198 | 428,547 (2%) | 0% | 29.3 | 181,787 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.90 per share. | 01 May 2023 | 775 | 434,745 (2%) | 0% | 29.9 | 23,173 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.85 per share. | 01 Mar 2023 | 4,045 | 435,520 (2%) | 0% | 31.8 | 128,833 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.67 per share. | 27 Feb 2023 | 433 | 439,565 (2%) | 0% | 32.7 | 14,146 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 14,573 | 440,739 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 2,142 | 426,166 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.65 per share. | 23 Feb 2023 | 741 | 439,998 (2%) | 0% | 31.7 | 23,453 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.99 per share. | 15 Feb 2023 | 1,018 | 424,024 (2%) | 0% | 34.0 | 34,602 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.21 per share. | 03 Feb 2023 | 4,408 | 425,042 (2%) | 0% | 36.2 | 159,614 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.75 per share. | 01 Feb 2023 | 624 | 429,450 (2%) | 0% | 34.8 | 21,684 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 34.39 per share. | 30 Nov 2022 | 685 | 430,074 (2%) | 0% | 34.4 | 23,559 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 35.89 per share. | 16 Nov 2022 | 1,306 | 430,759 (2%) | 0% | 35.9 | 46,873 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 220,816 | 220,816 (1%) | 1% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2022 | 129,309 | 432,065 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.89 per share. | 03 Nov 2022 | 6,198 | 302,756 (1%) | 0% | 37.9 | 234,842 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.25 per share. | 01 Nov 2022 | 775 | 308,954 (1%) | 0% | 40.3 | 31,194 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 44.18 per share. | 30 Aug 2022 | 675 | 309,729 (1%) | 0% | 44.2 | 29,824 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 48.89 per share. | 17 Aug 2022 | 1,414 | 310,404 (1%) | 0% | 48.9 | 69,137 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.93 per share. | 03 Aug 2022 | 6,343 | 311,818 (1%) | 0% | 62.9 | 399,165 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.54 per share. | 01 Aug 2022 | 872 | 318,161 (1%) | 0% | 59.5 | 51,919 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 54.54 per share. | 31 May 2022 | 668 | 319,033 (1%) | 0% | 54.5 | 36,433 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 58.29 per share. | 19 May 2022 | 10,000 | 319,701 (1%) | 0% | 58.3 | 582,866 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Sale of securities on an exchange or to another person at price $ 53.38 per share. | 16 May 2022 | 1,269 | 329,701 (1%) | 0% | 53.4 | 67,742 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 56.69 per share. | 03 May 2022 | 5,904 | 330,970 (1%) | 0% | 56.7 | 334,698 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | President and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 54.88 per share. | 01 May 2022 | 738 | 336,874 (1%) | 0% | 54.9 | 40,501 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 32,000 | 338,234 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 9,000 | 306,234 (1%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 63.30 per share. | 28 Feb 2022 | 622 | 337,612 (1%) | 0% | 63.3 | 39,370 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.49 per share. | 15 Feb 2022 | 936 | 297,234 (1%) | 0% | 66.5 | 62,235 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 63.15 per share. | 03 Feb 2022 | 4,029 | 298,170 (1%) | 0% | 63.1 | 254,431 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.34 per share. | 01 Feb 2022 | 504 | 302,199 (1%) | 0% | 65.3 | 32,931 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 95.42 per share. | 29 Nov 2021 | 636 | 302,703 (1%) | 0% | 95.4 | 60,686 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 95.50 per share. | 16 Nov 2021 | 1,214 | 303,339 (1%) | 0% | 95.5 | 115,940 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.12 per share. | 03 Nov 2021 | 5,904 | 304,553 (1%) | 0% | 88.1 | 520,260 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 86.79 per share. | 01 Nov 2021 | 738 | 310,457 (1%) | 0% | 86.8 | 64,051 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 91.25 per share. | 30 Aug 2021 | 622 | 311,195 (1%) | 0% | 91.3 | 56,760 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 95.12 per share. | 16 Aug 2021 | 1,223 | 311,817 (1%) | 0% | 95.1 | 116,335 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.46 per share. | 03 Aug 2021 | 23,615 | 313,040 (1%) | 0% | 100.5 | 2,372,363 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.25 per share. | 01 Aug 2021 | 739 | 336,655 (1%) | 0% | 92.3 | 68,173 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 73.46 per share. | 28 May 2021 | 647 | 337,394 (1%) | 0% | 73.5 | 47,527 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 72.21 per share. | 25 May 2021 | 2,000 | 338,041 (1%) | 0% | 72.2 | 144,412 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 74.48 per share. | 18 May 2021 | 1,000 | 340,041 (1%) | 0% | 74.5 | 74,480 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.71 per share. | 18 May 2021 | 931 | 341,041 (1%) | 0% | 70.7 | 65,831 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.02 per share. | 01 May 2021 | 504 | 341,972 (1%) | 0% | 77.0 | 38,818 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 104.10 per share. | 15 Mar 2021 | 3,000 | 342,476 (1%) | 0% | 104.1 | 312,300 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 102.65 per share. | 09 Mar 2021 | 62,000 | 345,476 (1%) | 0% | 102.6 | 6,364,219 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.26 per share. | 27 Feb 2021 | 403 | 407,476 (2%) | 0% | 101.3 | 40,808 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.09 per share. | 15 Feb 2021 | 806 | 407,879 (2%) | 0% | 161.1 | 129,839 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 137.91 per share. | 01 Feb 2021 | 504 | 408,685 (2%) | 0% | 137.9 | 69,507 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Dec 2020 | 22,500 | 409,189 (2%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.17 per share. | 30 Nov 2020 | 3,000 | 434,085 (2%) | 0% | 43.2 | 129,500 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 30 Nov 2020 | 1,000 | 431,689 (2%) | 0% | 46 | 46,000 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 45.16 per share. | 30 Nov 2020 | 1,000 | 432,689 (2%) | 0% | 45.2 | 45,160 | Common Stock |
| Fulgent Genetics Inc | Jian Xie | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 43.59 per share. | 30 Nov 2020 | 396 | 433,689 (2%) | 0% | 43.6 | 17,262 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges